The Human Proteome Project (HPP) was established by the Human Proteome Organization (HUPO) to explore the human proteome and to enable the routine, reliable and broad application of state-of the-art measurements of proteins and proteomes by life scientists studying the molecular mechanisms of biological processes and human disease (1). This will be accomplished through the generation of laboratory and informational resources that support both research and routine measurement of the process- or disease relevant proteins (2).

To accomplish these goals, the HPP reaches out to clinical scientists or clinicians who are using, or consider using, proteomics for their research projects (3). Since the 2015 congress in Vancouver, Canada the HPP has supported a number of clinical scientists with a travel grant to attend the HUPO World Congress. 

NOW OPEN - 2017 HPP Clinical Scientist Travel Grant Applications - Deadline June 30, 2017

Download the APPLICATION FORM

Past HPP Clinical Scientist Travel Grant recipients:

HUPO 2016 Taipei

• Peter Bergsten, Sweden
  
• Michael Chen, Canada
  
• David Herrington, USA
  
• Ana Konvalinka, Canada
  
• Vinayak Nagaraja, Australia 
  
• Zhiwei Qiao, Japan 
  

HUPO 2015 Vancouver

• Hyewon Chung, Korea
• Andrei Drabovich, Canada
• Johannes Griss, Austria
• Kurt Højlund, Denmark
• Heeyoun Hwang, Korea
• Ryan Ratts, USA
• Irene van den Broek, Netherlands

Reference

(1) Aebersold R, Bader GD, Edwards AM, van Eyk JE, Kussmann M, Qin J, Omenn GS. (2013) The Biology/Disease-driven Human Proteome Project (B/D-HPP): Enabling Protein Research for the Life Sciences Community. J Proteome Res. 2013 Jan 4;12(1):23-7. doi: 10.1021/pr301151m.

(2) Lane, L.; Bairoch, A.; Beavis, R. C.; Deutsch, E. W.; Gaudet, P.; Lundberg, E.; Omenn, G. S., Metrics for the Human Proteome Project 2013-2014 and strategies for finding missing proteins. J Proteome Res 2014, 13, 15-20.

3 The review committee will consider an application submitted by any clinical scientist or clinician who is or is considering using proteomics for their research including PhD-level scientist who are conducting clinical research.